Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Nasopharyngeal Carcinoma × nimotuzumab × Clear all

Phase

Status

Sponsor Class

OTHER 16 UNKNOWN 1 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Recurrence 1 Nasopharyngeal Carcinoma 1

Interventions

Cisplatin 5 Fluorouracil 4 Capecitabine 4 tislelizumab 2 Radiation 2 Gemcitabine 2 toripalimab 1 temoporfin 1 nimotuzumab 1 fludarabine 1 Taxes 1 Radiotherapy, Intensity-Modulated 1 Maintenance Chemotherapy 1 Drug Therapy 1 Cyclophosphamide 1 Cell Count 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03666221 2018-09-11

Nimotuzumab for Recurrent Nasopharyngeal Carcinoma

Fujian Cancer Hospital

Phase 2 Unknown

Nasopharyngeal Carcinoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡